Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BPH GlobalASX:BP8DF -50.00% Operating Cash Flow per Share is A$-0.00 as of Jun. 2026. The stock has 6 warning signs investors should review. Among 756 Drug Manufacturers companies, BPH Global ranks better than 85.45% on this metric.
BPH Global's operating cash flow per share for the
six
months ended in Jun. 2026 was A$-0.01.
BPH Global's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was A$-0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 45.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 41.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for BPH Global's Operating Cash Flow per Share or its related term are showing as below:
ASX:BP8DF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -280.2 Med: 12.6 Max: 52.2
Current: 45
During the past 13 years, BPH Global's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.20% per year. The lowest was -280.20% per year. And the median was 12.60% per year.
ASX:BP8DF's 3-Year OCF Growth Rate is ranked better than 85.45% of 756
companies
in the Drug Manufacturers industry
Industry Median: 7.25
vs ASX:BP8DF: 45.00
BPH Global Operating Cash Flow per Share Related Terms
BPH Global Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for BPH Global's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:BP8DF vs ZTS, UTHR: Operating Cash Flow per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BPH Global Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BPH Global's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where BPH Global's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of A$-0.00 mean?
BPH Global (ASX:BP8DF) has a Operating Cash Flow per Share of A$-0.00 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on BPH Global and its competitors. According to the industry distribution chart, BPH Global ranks #110 out of 756 companies in the Drug Manufacturers industry, placing it in the top 14.6%.
Is BPH Global's Operating Cash Flow per Share too high?
BPH Global's current Operating Cash Flow per Share is A$-0.00. Based on the distribution chart, BPH Global ranks #110 out of 756 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does BPH Global's Operating Cash Flow per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #110 out of 756 companies for Operating Cash Flow per Share. This places BPH Global in the top 15% of its industry — outperforming the majority of peers. The industry median Operating Cash Flow per Share is 7.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Drug Manufacturers company?
The median Operating Cash Flow per Share among Drug Manufacturers companies is 7.25, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on BPH Global and its competitors. For the Drug Manufacturers industry, the median Operating Cash Flow per Share is 7.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BPH Global's current Operating Cash Flow per Share is A$-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8DF) has a current Operating Cash Flow per Share of A$-0.00. The current Operating Cash Flow per Share is A$-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For BPH Global (ASX:BP8DF), the current Operating Cash Flow per Share is A$-0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BP8DF has been successfully added to your 
